Reply to Editorial Comment on “Contrasting Reasons for Early Termination Between Industry and Non-Industry-Led Clinical Trials in Genitourinary Oncology”
Reply to Editorial Comment on “Contrasting Reasons for Early Termination Between Industry and Non-Industry-Led Clinical Trials in Genitourinary Oncology”. // Urology. – URL: https://www.sciencedirect.com/science/article/pii/S0090429526007259?dgcid=rss_sd_all
Reply to Editorial Comment on “Contrasting Reasons for Early Termination Between Industry and Non-Industry-Led Clinical Trials in Genitourinary Oncology”. Urology. https://www.sciencedirect.com/science/article/pii/S0090429526007259?dgcid=rss_sd_all
“Reply to Editorial Comment on “Contrasting Reasons for Early Termination Between Industry and Non-Industry-Led Clinical Trials in Genitourinary Oncology”.” Urology.
@article{article70607,
title = {Reply to Editorial Comment on “Contrasting Reasons for Early Termination Between Industry and Non-Industry-Led Clinical Trials in Genitourinary Oncology”},
journal = {Urology},
url = {https://www.sciencedirect.com/science/article/pii/S0090429526007259?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...